Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Pan-cancer analyses of imaging-clinical phenotype associations using updated PLCO cohorts Kun-Hsing Yu President and Fellows of Harvard College PLCO Mar 25, 2024 PLCOI-1509
Clarifying Lung Cancer Risk Among Prostate Cancer Survivors Keith Sigel Icahn School of Medicine at Mount Sinai PLCO Mar 25, 2024 PLCO-1508
Identifying novel genetic factors predisposing to inherited cardiac disorders Connie Bezzina Amsterdam Universitair Medisch Centrum PLCO Mar 25, 2024 PLCO-1507
Advancing Lung Cancer Detection: Harnessing PLCO Trial X-Ray Imagery for Improved Diagnostic Algorithms Cheng He Mirxes Labs Pte. Ltd., Singapore PLCO Mar 25, 2024 PLCOI-1503
Low carbohydrate dietary score and prostate, ovarian, and lung cancer incidence Maryam Farvid George Mason University PLCO Mar 25, 2024 PLCO-1501
Lung and Cardiovascular Disease Detection with Large Scale, Disease Screening Chest X-rays Pingkun Yan Rensselaer Polytechnic Institute PLCO Mar 25, 2024 PLCOI-1505
Comparison of net endogenous acid production from dietary self-report instruments against recovery biomarker-derived measures Douglas Chang National Institute of Diabetes and Digestive and Kidney Diseases IDATA Mar 21, 2024 IDATA-71
Check if CXR can be implemented as a biomarker for aging. changduk Seo Kyungpook National University PLCO Mar 15, 2024 PLCOI-1497
Early Detection of Breast Cancer with AI enhanced workflows Dr. Tariq Mahmood Institute of Business Administration PLCO Mar 13, 2024 PLCO-1496
Segmentation of future lung cancer from LDCT screening scans. Daniel Truhn Department of Diagnostic and Interventional Radiology of the University Hospital Aachen (Germany) NLST Mar 12, 2024 NLST-1207
The utility of CT-based nodule characteristics and polygenic risk score in the setting of a lung cancer screening trial. Gerard Silvestri Medical University of South Carolina NLST Mar 11, 2024 NLST-1201
Anomaly Detection in Lung CT Scans through AWS SageMaker: A Machine Learning Approach Emma Kang University of California at Berkeley NLST Mar 11, 2024 NLST-1202
Computational Feature Profiling and Modeling for Prostate Cancer Detection and Risk Stratification Corey Arnold University of California, Los Angeles PLCO Mar 11, 2024 PLCOI-1492
Feasibility of colorectal and lung cancer screening using machine learning towards effective screening and early detection Sujin Kim University of Kentucky NLST Feb 29, 2024 NLST-1200
Assess positive-sum fairness of CXR classifiers leveraging demographic attributes Samia Belhadj Lunit Inc. PLCO Feb 27, 2024 PLCO-1490
Alcohol intake and the risk of colorectal adenomas and colorectal cancer in the PLCO (NCI Version) Erikka Loftfield (240)762-3319 PLCO Feb 27, 2024 PLCO-1489
Validation of a multimodal generative model for lung cancer and tuberculosis detection on chest radiograph in screening population Amy Hong Kakaobrain NLST Feb 26, 2024 NLST-1197
Long-Term Mortality Patterns Following Lung Cancer Subtype Resections: A Comparative Analysis of NLST Data Christopher Towe Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University NLST Feb 26, 2024 NLST-1196
Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence Christopher Towe Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University NLST Feb 26, 2024 NLST-1195
Ethnic and molecular diversity in prostate cancer Lisa Smith University of Nebraska at Omaha PLCO Feb 26, 2024 PLCO-1488